Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
A modification of the posterior auricular flap used for scapha and helix middle one-third defects of the auricle.

The Journal of craniofacial surgery

Çizmeci O, Mete FS, Kozanoğlu E, Kuvat SV.
PMID: 25974811
J Craniofac Surg. 2015 May;26(3):970-1. doi: 10.1097/SCS.0000000000001485.

No abstract available.

Cite
Çizmeci O, Mete FS, Kozanoğlu E, et al. A modification of the posterior auricular flap used for scapha and helix middle one-third defects of the auricle. J Craniofac Surg. 2015;26(3):970-1doi: 10.1097/SCS.0000000000001485.
Çizmeci, O., Mete, F. S., Kozanoğlu, E., & Kuvat, S. V. (2015). A modification of the posterior auricular flap used for scapha and helix middle one-third defects of the auricle. The Journal of craniofacial surgery, 26(3), 970-1. https://doi.org/10.1097/SCS.0000000000001485
Çizmeci, Orhan, et al. "A modification of the posterior auricular flap used for scapha and helix middle one-third defects of the auricle." The Journal of craniofacial surgery vol. 26,3 (2015): 970-1. doi: https://doi.org/10.1097/SCS.0000000000001485
Çizmeci O, Mete FS, Kozanoğlu E, Kuvat SV. A modification of the posterior auricular flap used for scapha and helix middle one-third defects of the auricle. J Craniofac Surg. 2015 May;26(3):970-1. doi: 10.1097/SCS.0000000000001485. PMID: 25974811.
Copy Download .nbib Format: NLM
T cell and antibody functional correlates of severe COVID-19.

medRxiv : the preprint server for health sciences

Yu KKQ, Fischinger S, Smith MT, Atyeo C, Cizmeci D, Wolf CR, Layton ED, Logue JK, Aguilar MS, Shuey K, Loos C, Yu J, Franko N, Choi RY, Wald A, Barouch DH, Koelle DM, Lauffenburger D, Chu HY, Alter G, Seshadri C.
PMID: 33269369
medRxiv. 2020 Nov 30; doi: 10.1101/2020.11.25.20235150.

Comorbid medical illnesses, such as obesity and diabetes, are associated with more severe COVID-19, hospitalization, and death. However, the role of the immune system in mediating these clinical outcomes has not been determined. We used multi-parameter flow cytometry and...

Cite
Yu KKQ, Fischinger S, Smith MT, et al. T cell and antibody functional correlates of severe COVID-19. medRxiv. 2020;doi: 10.1101/2020.11.25.20235150.
Yu, K. K. Q., Fischinger, S., Smith, M. T., Atyeo, C., Cizmeci, D., Wolf, C. R., Layton, E. D., Logue, J. K., Aguilar, M. S., Shuey, K., Loos, C., Yu, J., Franko, N., Choi, R. Y., Wald, A., Barouch, D. H., Koelle, D. M., Lauffenburger, D., Chu, H. Y., Alter, G., & Seshadri, C. (2020). T cell and antibody functional correlates of severe COVID-19. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.11.25.20235150
Yu, Krystle K Q, et al. "T cell and antibody functional correlates of severe COVID-19." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.11.25.20235150
Yu KKQ, Fischinger S, Smith MT, Atyeo C, Cizmeci D, Wolf CR, Layton ED, Logue JK, Aguilar MS, Shuey K, Loos C, Yu J, Franko N, Choi RY, Wald A, Barouch DH, Koelle DM, Lauffenburger D, Chu HY, Alter G, Seshadri C. T cell and antibody functional correlates of severe COVID-19. medRxiv. 2020 Nov 30; doi: 10.1101/2020.11.25.20235150. PMID: 33269369; PMCID: PMC7709190.
Copy Download .nbib Format: NLM
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.

Frontiers in immunology

Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ.
PMID: 28596770
Front Immunol. 2017 May 24;8:595. doi: 10.3389/fimmu.2017.00595. eCollection 2017.

A key aspect to finding an efficacious human immunodeficiency virus (HIV) vaccine is the optimization of vaccine schedules that can mediate the efficient maturation of protective immune responses. In the present study, we investigated the effect of alternate booster...

Cite
Kratochvil S, McKay PF, Kopycinski JT, et al. A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. Front Immunol. 2017;8:595doi: 10.3389/fimmu.2017.00595.
Kratochvil, S., McKay, P. F., Kopycinski, J. T., Bishop, C., Hayes, P. J., Muir, L., Pinder, C. L., Cizmeci, D., King, D., Aldon, Y., Wines, B. D., Hogarth, P. M., Chung, A. W., Kent, S. J., Held, K., Geldmacher, C., Dally, L., Santos, N. S., Cole, T., Gilmour, J., Fidler, S., & Shattock, R. J. (2017). A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. Frontiers in immunology, 8595. https://doi.org/10.3389/fimmu.2017.00595
Kratochvil, Sven, et al. "A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens." Frontiers in immunology vol. 8 (2017): 595. doi: https://doi.org/10.3389/fimmu.2017.00595
Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ. A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. Front Immunol. 2017 May 24;8:595. doi: 10.3389/fimmu.2017.00595. eCollection 2017. PMID: 28596770; PMCID: PMC5442169.
Copy Download .nbib Format: NLM
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.

PLoS pathogens

Fischinger S, Cizmeci D, Deng D, Grant SP, Frahm N, McElrath J, Fuchs J, Bart PA, Pantaleo G, Keefer M, O Hahn W, Rouphael N, Churchyard G, Moodie Z, Donastorg Y, Streeck H, Alter G.
PMID: 34843602
PLoS Pathog. 2021 Nov 29;17(11):e1010016. doi: 10.1371/journal.ppat.1010016. eCollection 2021 Nov.

Despite the advent of long-acting anti-retroviral therapy able to control and prevent infection, a preventative vaccine remains a global priority for the elimination of HIV. The moderately protective RV144 vaccine trial suggested functional IgG1 and IgG3 antibodies were a...

Cite
Fischinger S, Cizmeci D, Deng D, et al. Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials. PLoS Pathog. 2021;17(11):e1010016doi: 10.1371/journal.ppat.1010016.
Fischinger, S., Cizmeci, D., Deng, D., Grant, S. P., Frahm, N., McElrath, J., Fuchs, J., Bart, P. A., Pantaleo, G., Keefer, M., O Hahn, W., Rouphael, N., Churchyard, G., Moodie, Z., Donastorg, Y., Streeck, H., & Alter, G. (2021). Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials. PLoS pathogens, 17(11), e1010016. https://doi.org/10.1371/journal.ppat.1010016
Fischinger, Stephanie, et al. "Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials." PLoS pathogens vol. 17,11 (2021): e1010016. doi: https://doi.org/10.1371/journal.ppat.1010016
Fischinger S, Cizmeci D, Deng D, Grant SP, Frahm N, McElrath J, Fuchs J, Bart PA, Pantaleo G, Keefer M, O Hahn W, Rouphael N, Churchyard G, Moodie Z, Donastorg Y, Streeck H, Alter G. Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials. PLoS Pathog. 2021 Nov 29;17(11):e1010016. doi: 10.1371/journal.ppat.1010016. eCollection 2021 Nov. PMID: 34843602; PMCID: PMC8659322.
Copy Download .nbib Format: NLM
Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells.

Cell reports

Rossignol ED, Dugast AS, Compere H, Cottrell CA, Copps J, Lin S, Cizmeci D, Seaman MS, Ackerman ME, Ward AB, Alter G, Julg B.
PMID: 34038720
Cell Rep. 2021 May 25;35(8):109167. doi: 10.1016/j.celrep.2021.109167.

HIV monoclonal antibodies for viral reservoir eradication strategies will likely need to recognize reactivated infected cells and potently drive Fc-mediated innate effector cell activity. We systematically characterize a library of 185 HIV-envelope-specific antibodies derived from 15 spontaneous HIV controllers...

Cite
Rossignol ED, Dugast AS, Compere H, et al. Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells. Cell Rep. 2021;35(8):109167doi: 10.1016/j.celrep.2021.109167.
Rossignol, E. D., Dugast, A. S., Compere, H., Cottrell, C. A., Copps, J., Lin, S., Cizmeci, D., Seaman, M. S., Ackerman, M. E., Ward, A. B., Alter, G., & Julg, B. (2021). Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells. Cell reports, 35(8), 109167. https://doi.org/10.1016/j.celrep.2021.109167
Rossignol, Evan D, et al. "Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells." Cell reports vol. 35,8 (2021): 109167. doi: https://doi.org/10.1016/j.celrep.2021.109167
Rossignol ED, Dugast AS, Compere H, Cottrell CA, Copps J, Lin S, Cizmeci D, Seaman MS, Ackerman ME, Ward AB, Alter G, Julg B. Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells. Cell Rep. 2021 May 25;35(8):109167. doi: 10.1016/j.celrep.2021.109167. PMID: 34038720; PMCID: PMC8196545.
Copy Download .nbib Format: NLM
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.

PLoS pathogens

Fischinger S, Cizmeci D, Deng D, Grant SP, Frahm N, McElrath J, Fuchs J, Bart PA, Pantaleo G, Keefer M, O Hahn W, Rouphael N, Churchyard G, Moodie Z, Donastorg Y, Streeck H, Alter G.
PMID: 34843602
PLoS Pathog. 2021 Nov 29;17(11):e1010016. doi: 10.1371/journal.ppat.1010016. eCollection 2021 Nov.

Despite the advent of long-acting anti-retroviral therapy able to control and prevent infection, a preventative vaccine remains a global priority for the elimination of HIV. The moderately protective RV144 vaccine trial suggested functional IgG1 and IgG3 antibodies were a...

Cite
Fischinger S, Cizmeci D, Deng D, et al. Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials. PLoS Pathog. 2021;17(11):e1010016doi: 10.1371/journal.ppat.1010016.
Fischinger, S., Cizmeci, D., Deng, D., Grant, S. P., Frahm, N., McElrath, J., Fuchs, J., Bart, P. A., Pantaleo, G., Keefer, M., O Hahn, W., Rouphael, N., Churchyard, G., Moodie, Z., Donastorg, Y., Streeck, H., & Alter, G. (2021). Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials. PLoS pathogens, 17(11), e1010016. https://doi.org/10.1371/journal.ppat.1010016
Fischinger, Stephanie, et al. "Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials." PLoS pathogens vol. 17,11 (2021): e1010016. doi: https://doi.org/10.1371/journal.ppat.1010016
Fischinger S, Cizmeci D, Deng D, Grant SP, Frahm N, McElrath J, Fuchs J, Bart PA, Pantaleo G, Keefer M, O Hahn W, Rouphael N, Churchyard G, Moodie Z, Donastorg Y, Streeck H, Alter G. Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials. PLoS Pathog. 2021 Nov 29;17(11):e1010016. doi: 10.1371/journal.ppat.1010016. eCollection 2021 Nov. PMID: 34843602; PMCID: PMC8659322.
Copy Download .nbib Format: NLM
Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells.

Cell reports

Rossignol ED, Dugast AS, Compere H, Cottrell CA, Copps J, Lin S, Cizmeci D, Seaman MS, Ackerman ME, Ward AB, Alter G, Julg B.
PMID: 34038720
Cell Rep. 2021 May 25;35(8):109167. doi: 10.1016/j.celrep.2021.109167.

HIV monoclonal antibodies for viral reservoir eradication strategies will likely need to recognize reactivated infected cells and potently drive Fc-mediated innate effector cell activity. We systematically characterize a library of 185 HIV-envelope-specific antibodies derived from 15 spontaneous HIV controllers...

Cite
Rossignol ED, Dugast AS, Compere H, et al. Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells. Cell Rep. 2021;35(8):109167doi: 10.1016/j.celrep.2021.109167.
Rossignol, E. D., Dugast, A. S., Compere, H., Cottrell, C. A., Copps, J., Lin, S., Cizmeci, D., Seaman, M. S., Ackerman, M. E., Ward, A. B., Alter, G., & Julg, B. (2021). Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells. Cell reports, 35(8), 109167. https://doi.org/10.1016/j.celrep.2021.109167
Rossignol, Evan D, et al. "Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells." Cell reports vol. 35,8 (2021): 109167. doi: https://doi.org/10.1016/j.celrep.2021.109167
Rossignol ED, Dugast AS, Compere H, Cottrell CA, Copps J, Lin S, Cizmeci D, Seaman MS, Ackerman ME, Ward AB, Alter G, Julg B. Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells. Cell Rep. 2021 May 25;35(8):109167. doi: 10.1016/j.celrep.2021.109167. PMID: 34038720; PMCID: PMC8196545.
Copy Download .nbib Format: NLM
Tessier no. 3 incomplete cleft reconstruction with alar transposition and irregular z-plasty.

Plastic surgery international

Cizmeci O, Kuvat SV.
PMID: 22567244
Plast Surg Int. 2011;2011:596569. doi: 10.1155/2011/596569. Epub 2011 Jun 21.

Facial clefts are extremely rare congenital deformities and there are only a few technique reports for surgical reconstruction of clefts in the literature. In this article, we report a Tessier no. 3 incomplete cleft reconstruction with alar transposition and...

Cite
Cizmeci O, Kuvat SV. Tessier no. 3 incomplete cleft reconstruction with alar transposition and irregular z-plasty. Plast Surg Int. 2011;2011:596569doi: 10.1155/2011/596569.
Cizmeci, O., & Kuvat, S. V. (2011). Tessier no. 3 incomplete cleft reconstruction with alar transposition and irregular z-plasty. Plastic surgery international, 2011596569. https://doi.org/10.1155/2011/596569
Cizmeci, Orhan, and Kuvat, Samet Vasfi. "Tessier no. 3 incomplete cleft reconstruction with alar transposition and irregular z-plasty." Plastic surgery international vol. 2011 (2011): 596569. doi: https://doi.org/10.1155/2011/596569
Cizmeci O, Kuvat SV. Tessier no. 3 incomplete cleft reconstruction with alar transposition and irregular z-plasty. Plast Surg Int. 2011;2011:596569. doi: 10.1155/2011/596569. Epub 2011 Jun 21. PMID: 22567244; PMCID: PMC3335671.
Copy Download .nbib Format: NLM
Fat-Removal Orbital Decompressing for Severe Bilateral Proptosis due to Weber-Christian Disease.

The Journal of craniofacial surgery

Cizmeci O, Kuvat SV, Ceran F.
PMID: 25978784
J Craniofac Surg. 2015 May;26(3):984-5. doi: 10.1097/SCS.0000000000001513.

No abstract available.

Cite
Cizmeci O, Kuvat SV, Ceran F. Fat-Removal Orbital Decompressing for Severe Bilateral Proptosis due to Weber-Christian Disease. J Craniofac Surg. 2015;26(3):984-5doi: 10.1097/SCS.0000000000001513.
Cizmeci, O., Kuvat, S. V., & Ceran, F. (2015). Fat-Removal Orbital Decompressing for Severe Bilateral Proptosis due to Weber-Christian Disease. The Journal of craniofacial surgery, 26(3), 984-5. https://doi.org/10.1097/SCS.0000000000001513
Cizmeci, Orhan, et al. "Fat-Removal Orbital Decompressing for Severe Bilateral Proptosis due to Weber-Christian Disease." The Journal of craniofacial surgery vol. 26,3 (2015): 984-5. doi: https://doi.org/10.1097/SCS.0000000000001513
Cizmeci O, Kuvat SV, Ceran F. Fat-Removal Orbital Decompressing for Severe Bilateral Proptosis due to Weber-Christian Disease. J Craniofac Surg. 2015 May;26(3):984-5. doi: 10.1097/SCS.0000000000001513. PMID: 25978784.
Copy Download .nbib Format: NLM
Incorrect prescription of intravenous paracetamol in a pediatric patient.

Hippokratia

Orün E, Polat A, Andan H, Cizmeci N, Tufan N.
PMID: 23935350
Hippokratia. 2013 Jan;17(1):77-8.

Intravenous (IV) paracetamol is widely used for the treatment of pain and fever, when there is a clinical indication for an IV route. A 16-month-old girl weighing 12 kg had undergone anterior open reduction for developmental dysplasia of the...

Cite
Orün E, Polat A, Andan H, et al. Incorrect prescription of intravenous paracetamol in a pediatric patient. Hippokratia. 2013;17(1):77-8
Orün, E., Polat, A., Andan, H., Cizmeci, N., & Tufan, N. (2013). Incorrect prescription of intravenous paracetamol in a pediatric patient. Hippokratia, 17(1), 77-8.
Orün, E, et al. "Incorrect prescription of intravenous paracetamol in a pediatric patient." Hippokratia vol. 17,1 (2013): 77-8.
Orün E, Polat A, Andan H, Cizmeci N, Tufan N. Incorrect prescription of intravenous paracetamol in a pediatric patient. Hippokratia. 2013 Jan;17(1):77-8. PMID: 23935350; PMCID: PMC3738285.
Copy Download .nbib Format: NLM
Pregnancy has a minimal impact on the acute transcriptional signature to vaccination.

NPJ vaccines

Tregoning JS, Weiner J, Cizmeci D, Hake D, Maertzdorf J, Kaufmann SHE, Leroux-Roels G, Maes C, Aerssens A, Calvert A, Jones CE.
PMID: 32219001
NPJ Vaccines. 2020 Mar 25;5:29. doi: 10.1038/s41541-020-0177-6. eCollection 2020.

Vaccination in pregnancy is an effective tool to protect both the mother and infant; vaccines against influenza, pertussis and tetanus are currently recommended. A number of vaccines with a specific indication for use in pregnancy are in development, with...

Cite
Tregoning JS, Weiner J, Cizmeci D, et al. Pregnancy has a minimal impact on the acute transcriptional signature to vaccination. NPJ Vaccines. 2020;5:29doi: 10.1038/s41541-020-0177-6.
Tregoning, J. S., Weiner, J., Cizmeci, D., Hake, D., Maertzdorf, J., Kaufmann, S. H. E., Leroux-Roels, G., Maes, C., Aerssens, A., Calvert, A., & Jones, C. E. (2020). Pregnancy has a minimal impact on the acute transcriptional signature to vaccination. NPJ vaccines, 529. https://doi.org/10.1038/s41541-020-0177-6
Tregoning, John S, et al. "Pregnancy has a minimal impact on the acute transcriptional signature to vaccination." NPJ vaccines vol. 5 (2020): 29. doi: https://doi.org/10.1038/s41541-020-0177-6
Tregoning JS, Weiner J, Cizmeci D, Hake D, Maertzdorf J, Kaufmann SHE, Leroux-Roels G, Maes C, Aerssens A, Calvert A, Jones CE. Pregnancy has a minimal impact on the acute transcriptional signature to vaccination. NPJ Vaccines. 2020 Mar 25;5:29. doi: 10.1038/s41541-020-0177-6. eCollection 2020. PMID: 32219001; PMCID: PMC7096498.
Copy Download .nbib Format: NLM
Complete Genome Sequence of a Lineage IV Peste des Petits Ruminants Virus from Turkey, 2018.

Microbiology resource announcements

Hacıoğlu S, King S, Çizmeci ŞG, Yeşil Ö, Flannery J, Baron MD, Batten C, Rajko-Nenow PZ.
PMID: 32273369
Microbiol Resour Announc. 2020 Apr 09;9(15). doi: 10.1128/MRA.01446-19.

We report the whole-genome sequence of a peste des petits ruminants virus (PPRV) from a lamb exhibiting clinical signs in Turkey in September 2018. The genome of PPRV/Turkey/Central_Anatolia/2018 shows the highest nucleotide sequence identity (97.63%) to PPRV isolated in...

Cite
Hacıoğlu S, King S, Çizmeci ŞG, et al. Complete Genome Sequence of a Lineage IV Peste des Petits Ruminants Virus from Turkey, 2018. Microbiol Resour Announc. 2020;9(15)doi: 10.1128/MRA.01446-19.
Hacıoğlu, S., King, S., Çizmeci, �. �. G., Yeşil, �. �., Flannery, J., Baron, M. D., Batten, C., & Rajko-Nenow, P. Z. (2020). Complete Genome Sequence of a Lineage IV Peste des Petits Ruminants Virus from Turkey, 2018. Microbiology resource announcements, 9(15), . https://doi.org/10.1128/MRA.01446-19
Hacıoğlu, Sabri, et al. "Complete Genome Sequence of a Lineage IV Peste des Petits Ruminants Virus from Turkey, 2018." Microbiology resource announcements vol. 9,15 (2020). doi: https://doi.org/10.1128/MRA.01446-19
Hacıoğlu S, King S, Çizmeci ŞG, Yeşil Ö, Flannery J, Baron MD, Batten C, Rajko-Nenow PZ. Complete Genome Sequence of a Lineage IV Peste des Petits Ruminants Virus from Turkey, 2018. Microbiol Resour Announc. 2020 Apr 09;9(15). doi: 10.1128/MRA.01446-19. PMID: 32273369; PMCID: PMC7380515.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries